Safflower extract inhibiting apoptosis by inducing autophagy in myocardium derived H9C2 cell

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 11, 2015, Pages 20254-20262

  Jia, Zhisheng ^a   Liu, Yancai ^a   Su, Huailing ^a   Li, Ming ^a   Zhang, Min ^a   Zhu, Ye ^a   Li, Tenjiao ^a   Fang, Youbo ^a   Liang, Shimin ^a  

^a The Fifth People's Hospital of Jinan   (China)

Author keywords

Apoptosis; Autophagy; Heart failure; Pro apoptotic genes; Safflower extract

Indexed keywords

3 METHYLADENINE; ANGIOTENSIN II; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN BAD; PROTEIN BAX; RAPAMYCIN; SAFFLOWER EXTRACT;

ANIMAL CELL; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HEART MUSCLE; IMMUNOFLUORESCENCE TEST; LIGHT CHAIN; MTT ASSAY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; SAFFLOWER; WESTERN BLOTTING;

EID: 84954271486     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cleland JG, Khand A and Clark A. The heart failure epidemic: exactly how big is it? Eur Heart J 2001; 22: 623-626.
2. Fujita T and Ishikawa Y. Apoptosis in heart failure.-The role of the beta-adrenergic receptor mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes. Circ J 2011; 75: 1811-1818.
3. Grazette LP and Rosenzweig A. Role of apoptosis in heart failure. Heart Fail Clin 2005; 1: 251-261.
4. In: editors. Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update. London: 2010.
5. McMurray JJ and Pfeffer MA. Heart failure. Lancet 2005; 365: 1877-1889.
6. Kang PM and Izumo S. Apoptosis and heart failure: A critical review of the literature. Circ Res 2000; 86: 1107-1113.
7. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW and Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182-1189.
8. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M and Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996; 335: 1190-1196.
9. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M and Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 1997; 95: 320-323.
10. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, Kinugawa S and Tsutsui H. Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardiovasc Res 2006; 70: 457-465.
11. Naito AT, Okada S, Minamino T, Iwanaga K, Liu ML, Sumida T, Nomura S, Sahara N, Mizoroki T, Takashima A, Akazawa H, Nagai T, Shiojima I and Komuro I. Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury. Circ Res 2010; 106: 1692-1702.
12. Das B, Young D, Vasanji A, Gupta S, Sarkar S and Sen S. Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure. Cardiovasc Res 2010; 87: 524-534.
13. Tomita H, Nazmy M, Kajimoto K, Yehia G, Molina CA and Sadoshima J. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation. Circ Res 2003; 93: 12-22.
14. Zhu WZ, Wang SQ, Chakir K, Yang D, Zhang T, Brown JH, Devic E, Kobilka BK, Cheng H and Xiao RP. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/ calmodulin kinase II. J Clin Invest 2003; 111: 617-625.
15. Li YL, Ju JQ, Yang CH, Jiang HQ, Xu JW and Zhang SJ. Oral Chinese herbal medicine for improvement of quality of life in patients with chronic heart failure: a systematic review and meta-analysis. Qual Life Res 2014; 23: 1177-1192.
16. Tang WH and Huang Y. Cardiotonic modulation in heart failure: insights from traditional Chinese medicine. J Am Coll Cardiol 2013; 62: 1073-1074.
17. Bai H, Li Y, Han K, Gong M and Ma A. Effectiveness of Chinese herbal medicine as an adjunctive treatment for dilated cardiomyopathy in patients with heart failure. J Altern Complement Med 2013; 19: 811-819.
18. Chen J, Yao Y, Chen H and Kwong JS. Shengmai (a traditional Chinese herbal medicine) for heart failure. Cochrane Database Syst Rev 2012; 11: CD005052.
19. Wen-Ting S, Fa-Feng C, Li X, Cheng-Ren L and Jian-Xun L. Chinese medicine shenfu injection for heart failure: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2012; 2012: 713149.
20. Fu S, Zhang J, Menniti-Ippolito F, Gao X, Galeotti F, Massari M, Hu L, Zhang B, Ferrelli R, Fauci A, Firenzuoli F, Shang H, Guerra R and Raschetti R. Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review. PLoS One 2011; 6: e19604.
21. Zheng H, Chen Y, Chen J, Kwong J and Xiong W. Shengmai (a traditional Chinese herbal medicine) for heart failure. Cochrane Database Syst Rev 2011; CD005052.
22. Luo L, Chen J, Guo S, Wang J, Gao K, Zhang P, Chen C, Zhao H and Wang W. Chinese Herbal Medicine in the Treatment of Chronic Heart Failure: Three-Stage Study Protocol for a Randomized Controlled Trial. Evid Based Complement Alternat Med 2015; 2015: 927160.
23. Patel D, Nan Y, Shen M, Ritthipichai K, Zhu X and Zhang YJ. Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation. J Virol 2010; 84: 11045-11055.
24. Nan Y, Wang R, Shen M, Faaberg KS, Samal SK and Zhang YJ. Induction of type I interferons by a novel porcine reproductive and respiratory syndrome virus isolate. Virology 2012; 432: 261-270.
25. Nan Y, Ma Z, Wang R, Yu Y, Kannan H, Fredericksen B and Zhang YJ. Enhancement of interferon induction by ORF3 product of hepatitis E virus. J Virol 2014; 88: 8696-8705.
26. Nan Y, Ma Z, Kannan H, Stein DA, Iversen PI, Meng XJ and Zhang YJ. Inhibition of hepatitis E virus replication by peptide-conjugated mor pholino oligomers. Antiviral Res 2015; 120: 134-139.
27. Fan S, Lin N, Shan G, Zuo P and Cui L. Safflower yellow for acute ischemic stroke: A systematic review of randomized controlled trials. Complement Ther Med 2014; 22: 354-361.
28. Zhou MX, Fu JH, Zhang Q and Wang JQ. Effect of hydroxy safflower yellow A on myocardial apoptosis after acute myocardial infarction in rats. Genet Mol Res 2015; 14: 3133-3141.
29. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J and Tabas I. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 2012; 15: 545-553.
30. Ritthipichai K, Nan Y, Bossis I and Zhang Y. Viral FLICE inhibitory protein of rhesus monkey rhadinovirus inhibits apoptosis by enhancing autophagosome formation. PLoS One 2012; 7: e39438.
31. Tanida I, Ueno T and Kominami E. LC3 and Autophagy. Methods Mol Biol 2008; 445: 77-88.
32. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB and Greenberg ME. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 2000; 6: 41-51.
33. Oltvai ZN, Milliman CL and Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
34. Li LJ, Li YM, Qiao BY, Jiang S, Li X, Du HM, Han PC and Shi J. The Value of Safflower Yellow Injection for the Treatment of Acute Cerebral Infarction: A Randomized Controlled Trial. Evid Based Complement Alternat Med 2015; 2015: 478793.